Importantly, in a head‐to‐head comparison, adrenomedullin (ADM), IL‐6 and procalcitonin (PCT) all outperformed BNP in predicting CS mortality.38, 46, 74. This evidence concerns the gene ADM and Cowden syndrome 1.